Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion

Neuroendocrinology

Volumn 68, Issue 2, 1998, Pages 123-128

  Ambrosio, Maria R ^a   Campo, Michela ^a   Zatelli, Maria C ^a   Cella, Silvano G ^b   Trasforini, Giorgio ^a   Margutti, Angela ^a   Rigamonti, Antonello E ^b   Müller, Eugenio E ^b   Degli Uberti, Ettore C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Aging; Clinical neuroendocrinology; Corticotropin; Growth hormone; Somatostatin

Indexed keywords

CORTICOTROPIN; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; SOMATOSTATIN;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AGING; BLOOD GLUCOSE; FEMALE; HORMONE ANTAGONISTS; HUMAN GROWTH HORMONE; HUMANS; HYDROCORTISONE; MALE; PITUITARY-ADRENAL SYSTEM; SOMATOSTATIN;

EID: 0031876478     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054358     Document Type: Article

References (40)

1. Rivier C, Vale W: Corticotropin-releasing factor (CRF) acts centrally to inhibit growth hormone secretion in the rat. Endocrinology 1984; 114:2409-2411.
2. Katakami H, Arimura A, Frohman LA: Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats. Neuroendocrinology 1985;41: 390-393.
3. Wehrenberg WB, Baird A, Ling N: Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo. Science 1983;221:556-558.
4. Casanueva FF, Burguera B, Muruais C, Diegue C: Acute administration of corticoids: A new and peculiar stimulus of growth hormone secretion in man. J Clin Endocrinol Metab 1990; 70:234-237.
5. Gick GG, Bancroft C: Glucocorticoid stimulation of growth hormone messenger ribonucleic acid levels in GH3 cells is inhibited by calcium but not by somatostatin. Endocrinology 1987; 120:1986-1990.
6. Giustina A, Romanelli G, Candrina R, Giustina G: Growth hormone deficiency in patients with idiopathic adrenocorticotropin deficiency resolves during glucocorticoid replacement. J Clin Endocrinol Metab 1989;68:120-124.
7. Wehrenberg WB, Janowski BA, Piering AW, Culler F, Jones KL: Glucocorticoids: Potent inhibitors and stimulators of growth hormone secretion. Endocrinology 1990;126: 3200-3203.
8. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP: Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab 1994;78:131-137.
9. Faglia G, Arosio M, Ambrosi B: Recent advances in diagnosis and treatment of acromegaly; in Imura H (ed): The Pituitary Gland. New Xork, Raven Press, 1994, pp 411-451.
10. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE: Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979;301: 1138-1142.
11. Schteingart DE: Suppression of cortisol secretion by human growth hormone. J Clin Endocrinol Metab 1980;50:721-725.
12. Tait PG: The use of isotopic steroids for measurement of production rates in vivo. J Clin Endocrinol 1963;23:1287-1297.
13. degli Uberti EC, Ambrosio MR, Cella SG, Margutti AR, Trasforini G, Rigamonti AE, Petrone E, Müller EE: Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. J Clin Endocrinol Metab 1997;82:2885-2888.
14. Hall R, Besser BM, Schally AV, Coy DH, Evered D, Goldie DJ, Kastin AJ, McNeilly AS, Mortimer CH, Phenekos C, Tunbridge WMG, Weightman D: Action of growth-hormone-release-inhibitory hormone in healthy men and in acromegaly. Lancet 1973;ii:581-584.
15. Stafford PJ, Kopelman PG, Davidson K, McLoughlin L, White A, Rees LH, Besser GM, Coy DH, Grossman A: The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects. Clin Endocrinol 1989;30:661-666.
16. Volpi R, Chiodera P, Capretti L, Caiazza A, Caffarri G, Magotti MG, Boni S, Coiro V: Inhibition by somatostatin of the growth hormone, but not corticotropin response to angiotensin II in normal men. Horm Res 1996;45:269-272.
17. Richardson UI, Schonbrunn A: Inhibition of adrenocorticotropin secretion by somatostatin in pituitary cells in culture. Endocrinology 1981;108:281-290.
18. Nicholson SA, Adrian TE, Gillham B, Jones MT, Bloom SR: Effect of hypothalamic neuropeptides on corticotrophin release from quarters of rat anterior pituitary gland in vitro. J Endocrinol 1984;100:219-226.
19. Brown MR, Rivier C, Vale W: Central nervous system regulation of adrenocorticotropin secretion: Role of somatostatins. Endocrinology 1984;114:1546-1549.
20. Benker G, Hackenberg K, Hamburger B, Renwein D: Effects of growth hormone release inhibiting hormone and bromocriptine (CB 154) in states of abnormal pituitary-adrenal function. Clin Endocrinol 1976;5:187-190.
21. Tyrrel JB, Lorenzi M, Gehrich JE, Forsham PH: Inhibition by somatostatin of ACTH secretion in Nelson's syndrome. J Clin Endocrinol Metab 1975;40:1125-1127.
22. Fehm HL, Voigt KH, Lang R, Beinert KE, Raptis S, Pfeiffer EF: Somatostatin: A potent inhibitor of ACTH-hypersecretion in adrenal insufficiency. Klin Wochenschr 1976;54:173-176.
23. Petraglia F, Facchinetti F, D'Ambrogio G, Volpe A, Genazzani AR: Somatostatin and oxytocin infusion inhibits the rise of plasma beta-endorphin and beta-lipotropin and cortisol induced by insulin hypoglycaemia. Clin Endocrinol 1986;24:609-616.
24. Frieboes RM, Murck H, Schier T, Holsboer F, Steiger A: Somatostatin impairs sleep in elderly human subjects. Neuropsychopharmacology 1997;16:339-345.
25. Gertz BJ, Barret JS, Eisenhandler R, Krupa DA, Wittreich JM, Seibol JR, Schneider SH: Growth hormone response in man to L-692, 429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab 1993;77:1393-1397.
26. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO: Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990;70:975-982.
27. Frieboes RM, Murck H, Maier P, Schier T, Holsboer F, Steiger A: Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man. Neuroendocrinology 1995;61:584-589.
28. Pong SS, Chaung LY, Dean DC, Nargund RP, Patchett AA, Smith RG: Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996;10: 57-61.
29. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Patchett AA, Nargund R, Griffin PR, De Martino JA, Gupta SK, Schaeffer GM, Smitter RG, Van der Ploeg LH, et al: A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996;273:974-977.
30. Korbonits M, Little JA, Forsling M, Trainer PJ, Besser GM, Grossman AB: The effect of growth hormone secretagogues on GHRH and arginine vasopressin release from the rat hypothalamus in vitro. Abstr Book Endo '97 1997; P1-74:153.
31. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerik J: Hierarchy of glycemic thresholds for counter-regulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol 1991;260: E67-E74.
32. Sapolsky RM, Krey LC, McEwen BS: The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284-301.
33. Seeman TE, Robbins RJ: Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994;15:233-260.
34. Landfield PW, Waymire JC, Lynch G: Hippocampal aging and adrenocorticoids: Quantitative correlation. Science 1978;202:1098-1102.
35. Sapolsky RM, Krey LC, McEwen BS: Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. J Neurosci 1985;5:1222-1227.
36. Oxenkrug GF, Pomara N, McIntyre IM, Branconnier RJ, Stanley M, Gershon S: Aging and cortisol resistance to suppression by dexamethasone: A positive correlation. Psychiatry Res 1983;10:125-130.
37. Heuser IJ, Gotthardt U, Schweiger U, Schmider J, Lammers CH, Dettling M, Holsboer U: Age associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiol Aging 1994;15: 227-231.
38. Holsboer F, von Bardeleben U, Steiger A: Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology 1988;48:32-38.
39. Wiedemann K, von Bardeleben U, Holsboer F: Influence of human corticotropin-releasing hormone and adrenocorticotropin upon spontaneous growth hormone secretion. Neuroendocrinology 1991;54:462-468.
40. Steiger A, Guldner J, Hemmeter U, Rothe B, Wiedemann K, Holsboer F: Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 1992;56: 566-573.